Sanofi-Synthelabo

Corporate Assignee

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Corporate Assignee

active

No affiliations

1,3-dihydro-2h-indol-2-one derivatives and their use as...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

1,3-dihydro-2H-indol-2-one derivatives, preparation method...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

1,3-dihydro-2h-indol-2-one, preparation method and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

1,4-diazabicyclo [2.2.2] oct-2-ylmethyl derivatives, their prepa

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

1,4-diazabicyclo[3.2.2]nonane-phenylisoxazole derivatives,...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Sanofi-Synthelabo does not yet have a rating. At this time, there are no reviews or comments for this inventor.

If you have personal experience with Sanofi-Synthelabo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sanofi-Synthelabo will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-P-210346

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.